教育背景 2013.09–2016.06 中国药科大学 药理学 博士 2008.09–2011.07 北京协和医学院 药理学 硕士 2004.09–2008.07 中国药科大学 海洋药学 本科 工作经历 2016.09–至今 南京工业大学，药学院，讲师 2012.05–2013.07 默沙东中国有限公司，数据管理专员（药物警戒） 2011.7–2012.04 贝克曼库尔特商贸（中国）有限公司，临床研究专员

肿瘤药理学 心血管药理学 代谢组学

1) Sun Yang, Zhao Yue, Yao Jing, Zhao Li, Wu Zhaoqiu, Wang Yu, Pan Di, Miao Hanchi, Guo Qinglong, Lu Na. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation. Biochemical Pharmacology. 2015; 94(2):142-54. doi: 10.1016/j.bcp.2015.02.002. (IF=5.009) 2) Sun Yang1, Zhao Yue1, Xiaoping Wang, Zhao Li, Li Wenjun, Ding Youxiang, Pan Chuyue, Guo Qinglong, Na Lu. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer cell proliferation in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway. Oncotarget. 2016 Apr 18. doi: 10.18632/ oncotarget.8815. (IF=6.359) 3) Sun Yang, Lian Zeqin, Jiang Chunying, Wang Yinghong, Zhu Haibo. Beneficial metabolic effects of 2',3',5'-tri-acetyl-N6- (3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters. PLoS One. 2012; 7(3):e32115. doi: 10.1371/journal.pone.0032115. (IF=4.092) 4) Sun Yang, Wang Yinghong, Qu Kai, Zhu Haibo. Beneficial effects of cordycepin on metabolic profiles of liver and plasma from hyperlipidemic hamsters. Journal of Asian Natural Producst Research. 2011; 13(6):534-46. doi: 10.1080/10286020.2011.575364. (IF=0.944) 5) Zhao Yue1, Sun Yang1, Ding Youxiang, Wang Xiaoping, Zhou Yuxin, Li Wenjun, Huang Shaoliang, Li Zhiyu, Guo Qinglong and Lu Na. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1expression via activation of AMPK/FOXO3a pathway. Oncotarget. 2015 Sep 22;6(28):26291-307. doi: 10.18632/oncotarget.4657. (IF=6.359) 6) Wang Xiaoping1, Sun Yang1, Zhao Yue, Ding Youxiang, Zhang Xiaobo, Kong Lingyi, Li Zhiyu, Guo Qinglong, Zhao Li. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation. Biochemical Pharmacology. 2016; 106: 70-81 doi: 10.1016/j.bcp.2016.02.019. (IF=5.009) 7) Zhao Yue, Wang Xiaoping, Sun Yang, Zhou Yuxin, Yin Yuehan, Ding Youxiang, Li Zhiyu, Guo Qinglong, Lu Na. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells. Apoptosis. 2015; 20(9): 1253-69. doi: 10.1007/s10495-015- 1145-x. (IF= 3.685) 8) Zhao Li, Miao Hanchi, Li Wenjun, Sun Yang, Huang Shaoliang, Li Zhiyu, Guo Qinglong. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells. Molecular Carcinogenesis. 2015 May 6. doi: 10.1002/mc.22321. [Epub ahead of print] (IF=4.808) 9) Yao Jing, Zhao Li, Zhao Qing, Zhao Yue, Sun Yang, Zhang Yi, Miao Hanchi, You Qidong, Hu Rong, Guo Qinglong. NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis. Cell Death and Disease. (2014) 5, e1283; doi:10.1038/cddis.2014.221(IF=5.014) 10) Wang Yu, Miao Hanchi, Li Wei, Yao Jing, Sun Yang, Li Zhiyu, Zhao Li, Guo Qinglong. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. Biochemical Pharmacology. 2014; 90 (3): 212-25. doi: 10.1016/j.bcp.2014.05.007. (IF= 4.65)